Cytec Industries Inc. v Nalco Company (No 3)

Link copied
Case Copied 13 min read

FEDERAL COURT OF AUSTRALIA

Cytec Industries Inc. v Nalco Company (No 3) [2021] FCA 1332   

File number(s): NSD 130 of 2019
Judgment of: BURLEY J
Date of judgment: 1 November 2021
Catchwords: COSTS – where appellant succeeded in its opposition to the grant of patent application – where not all grounds of appeal successful – where grace period argument raised late – respondent to pay 70% of appellant’s costs  
Legislation:

Federal Court of Australia Act 1976 (Cth) ss 37M and 37N

Patents Act 1990 (Cth) ss 7, 24(1)(a) and 40(2)(aa)

Cases cited:

Cytec Industries Inc. v Nalco Company [2021] FCA 970

Idenix Pharmaceuticals LLC v Gilead Sciences Pty Ltd (No 2) [2018] FCAFC 7

Meat & Livestock Australia Ltd v Cargill (No 2) [2019] FCA 33; 139 IPR 47

Division: General Division
Registry: New South Wales
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Number of paragraphs: 17
Date of last submission/s: 12 October 2021
Counsel for the Appellant: Mr C Dimitriadis SC
Solicitor for the Appellant: Allens
Counsel for the Respondent: Mr J S Cooke with Ms M Evetts
Solicitor for the Respondent: Shelston Lawyers

ORDERS

NSD 130 of 2019
BETWEEN:

CYTEC INDUSTRIES INC

Appellant

AND:

NALCO COMPANY

Respondent

AND BETWEEN:

NALCO COMPANY

Cross-Appellant

AND:

CYTEC INDUSTRIES INC

Cross-Respondent

ORDER MADE BY:

BURLEY J

DATE OF ORDER:

1 NOVEMBER 2021

THE COURT ORDERS THAT:

1.The Respondent/Cross-Appellant pay 70% of the Appellant’s/Cross-Respondent’s costs of the proceedings, including costs reserved by order 3 of the orders made on 27 August 2020.

2.Any disputed assessment of the quantum of the costs in order 1 be determined by a Registrar of the Court, such determination to be deferred until the conclusion of the proceedings.

Note:   Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.


REASONS FOR JUDGMENT

BURLEY J:

1.                 INTRODUCTION

  1. In Cytec Industries Inc. v Nalco Company [2021] FCA 970 (judgment) I found that Cytec Industries Inc. succeeded in its opposition to the grant of patent application number 2012220990 entitled “Reducing aluminosilicate scale in the Bayer process”. I expressed the preliminary view at [226] that having regard to the relative success of the parties the respondent (and patent applicant) Nalco Company should pay 70% of Cytec’s costs, but invited the parties to make submissions should they disagree.

  2. It turns out that that they do disagree.

  3. Nalco submits that it should be required to pay 30% of Cytec’s costs. Cytec submits that the correct figure is 70%. For the reasons set out below, in my view, Nalco should pay 70% of Cytec’s costs of the proceedings. These reasons assume familiarity with the judgment.

    2.                 THE SUBMISSIONS

  4. Cytec submits that it was successful in the appeal from the delegate’s decision on two grounds, lack of support and lack of clear and complete disclosure, and that whilst some discount to a costs order in its favour is appropriate having regard to its failure to establish grounds of opposition based on lack of novelty…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Cytec Industries Inc. v Nalco Company (No 3) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2021] FCA 1332
Decision Date

CaseChat Overview and Summary

In Cytec Industries Inc. v Nalco Company, the Federal Court considered the issue of costs following an opposition to the grant of a patent application. Cytec Industries Inc. successfully opposed the grant of patent application number 2012220990, which was owned by Nalco Company. The central issue before the court was the appropriate percentage of costs that Nalco should pay to Cytec, given Cytec's partial success in the appeal.

The legal issues revolved around the principles of cost allocation in patent disputes, particularly the relative success of the parties. Cytec argued for a 70% costs order in its favour, given its success on the primary issues of lack of support and lack of clear and complete disclosure. Nalco contended that the costs should be apportioned at 30%, as Cytec had not succeeded on all grounds, and much of the hearing time was spent on unsuccessful arguments. Nalco also pointed out that Cytec abandoned several grounds of opposition before the hearing.

The court considered the principles of cost allocation, noting that while the general rule is that costs follow the event, the court has a broad discretion to award costs. The court found that Cytec was successful on the primary issues and that while some discount to the costs order was appropriate due to Cytec's unsuccessful arguments, the 70% assessment was justified given the significant success on the critical issues. The court also noted that the grace period argument was raised late, and therefore the reserved costs related to this argument should be resolved in Nalco's favour.

The court concluded that Nalco should pay 70% of Cytec's costs, but any disputed assessment of the quantum of these costs should be determined by a Registrar of the Court, deferred until the conclusion of the proceedings. The court's decision was based on the relative success of the parties and the principles of cost allocation in patent disputes.

Orders

Orders of the court

1. The Respondent/Cross-Appellant pay 70% of the Appellant’s/Cross-Respondent’s costs of the proceedings, including costs reserved by order 3 of the orders made on 27 August 2020.

2. Any disputed assessment of the quantum of the costs in order 1 be determined by a Registrar of the Court, such determination to be deferred until the conclusion of the proceedings.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

In Cytec Industries Inc. v Nalco Company [2021] FCA 970 (judgment) I found that Cytec Industries Inc. succeeded in its opposition to the grant of patent application number 2012220990 entitled “Reducing aluminosilicate scale in the Bayer process”. I expressed the preliminary view at [226] that having regard to the relative success of the parties the respondent (and patent applicant) Nalco Company should pay 70% of Cytec’s costs, but invited the parties to make submissions should they disagree. It turns out that that they do disagree. Nalco submits that it should be required to pay 30% of Cytec’s costs. Cytec submits that the correct figure is 70%. For the reasons set out below, in my view, Nalco should pay 70% of Cytec’s costs of the proceedings. These reasons assume familiarity with the judgment.2. THE SUBMISSIONS Cytec submits that it was successful in the appeal from the delegate’s decision on two grounds, lack of support and lack of clear and complete disclosure, and that whilst some discount to a costs order in its favour is appropriate having regard to its failure to establish grounds of opposition based on lack of novelty within s 7(1) of the Patents Act 1990 (Cth) and failure to disclose best method within s 40(2)(aa) of the Patents Act, the assessment of 70% is appropriate. Nalco advances a number of reasons in favour of its proposed costs order. It submits that Cytec’s success turned on a single construction issue, being the “single small molecule argument”, which turned principally upon the language of the claims. In contrast, the majority of the time spent at the hearing was directed to Cytec’s unsuccessful grounds. It provides a count of transcript pages the subject of contentious issues to support the submission that the bulk of the time of the hearing was directed to Cytec’s unsuccessful grounds. It submits that the circumstances of this case are analogous to those in Meat & Livestock Australia Ltd v Cargill (No 2) [2019] FCA 33; 139 IPR 47 (Beach J). Nalco notes that Cytec abandoned a number of grounds of opposition prior to the hearing and that the costs consequent upon the abandonment of arguments going to: (a) deferred priority date; (b) lack of inventive step in light of WO 873 and WO 2008/045677; and (c) lack of novelty in relation to a deferred priority date were reserved on 27 August 2020. It submits that these reserved costs should be resolved in its favour having regard to Cytec’s late abandonment of arguments in light of Nalco raising the grace period argument. I address the grace period argument in the judgment in section 9.2.3. CONSIDERATION The principles relevant to the determination of costs are not in dispute and were aptly summarised by the Full Court in Idenix Pharmaceuticals LLC v Gilead Sciences Pty Ltd (No 2) [2018] FCAFC 7 (Nicholas, Beach and Burley JJ) at [3]:The power of the Court in relation to costs is well established. Section 43 of the Federal Court of Australia Act1976 (Cth) gives the Court a wide discretion in awarding costs. The exercise of the Court's discretion is not without principles or practices; it must be exercised judicially (Les Laboratoires Servier v Apotex Pty Ltd (2016) 247 FCR 61 at [305] per Bennett, Besanko and Beach JJ). The ordinary rule is that costs follow the event, although a successful party may be awarded less than its costs, or costs may be apportioned, based upon success on the issues (Firebird Global Master Fund II Ltd v Republic of Nauru (No 2) (2015) 327 ALR 192; [2015] HCA 53 at [6] per French CJ, Kiefel, Nettle and Gordon JJ; Les Laboratoires Servier at [297] to [298] and [303]).

Ratio Decidendi

Legal Principle Established